GE Healthcare AG - Clariscan, Injektionslösung |
| 66262 | | 01 | | Clariscan | | Injektionslösung | | V08CA02 | | Gadotersäure | | 05.07.2017 | | |
|
Composition |
acidum gadotericum 279.3 mg corresp. gadolinium 0.5 mmol, megluminum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
Packungsbestandteile |
| Solution injectable | | | | | | Principe actif | Concentr. |
---|
Acide Gadoterique | 279.3 mg/ml |
| BAG: Principe actif | Concentr. |
---|
Acide Gadoterique | 27.93 g |
| | Agents auxilliaires |
---|
Meglumine |
| |
|
|